VITASPRING BIOMEDICAL CO. LTD. (VSBC) Corporate Subsidiaries
VITASPRING BIOMEDICAL CO. LTD. (VSBC) is a publicly traded company on the OTC, categorized under SIC 8731 (Services-Commercial Physical & Biological Research). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VSBC
CIK: 1697884
Exchange: OTC
SIC 8731: Services-Commercial Physical & Biological Research
Fiscal Year End: 01/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
JP CENTURION & PARTNERS PLT
Auditor SinceSince 1/31/2023 12:00:00 AM
Lead Engagement PartnerWeng Sum Ng
Audit LocationKuala Lumpur, Malaysia
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-09-17 | 2026-07-31 | FORM 10-Q | 0001640334-26-001572 | View SEC Doc Filr Page |
| NT 10-Q | 2026-09-15 | 2026-07-31 | FORM NT 10-Q | 0001640334-26-001541 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-07 | FORM 8-K | 0001640334-26-001485 | View SEC Doc Filr Page |
| 10-K | 2026-06-17 | 2026-01-31 | FORM 10-K | 0001640334-26-001082 | View SEC Doc Filr Page |
| 10-Q | 2026-06-17 | 2026-04-30 | FORM 10-Q | 0001640334-26-001083 | View SEC Doc Filr Page |
| 10-Q | 2026-06-17 | 2025-10-31 | FORM 10-Q | 0001640334-26-001077 | View SEC Doc Filr Page |
| 10-Q | 2026-06-17 | 2025-07-31 | FORM 10-Q | 0001640334-26-001075 | View SEC Doc Filr Page |
| 10-Q | 2026-06-15 | 2025-04-30 | FORM 10-Q | 0001640334-26-001046 | View SEC Doc Filr Page |
| 10-K | 2026-06-08 | 2025-01-31 | FORM 10-K | 0001640334-26-001019 | View SEC Doc Filr Page |
| 10-Q | 2026-05-06 | 2024-10-31 | FORM 10-Q | 0001640334-26-000831 | View SEC Doc Filr Page |
| 10-Q | 2026-04-22 | 2024-07-31 | FORM 10-Q | 0001640334-26-000788 | View SEC Doc Filr Page |
| 10-Q | 2026-04-02 | 2024-04-30 | FORM 10-Q | 0001640334-26-000615 | View SEC Doc Filr Page |
| 10-K | 2026-03-12 | 2024-01-31 | FORM 10-K | 0001640334-26-000426 | View SEC Doc Filr Page |
| 10-Q | 2026-01-30 | 2023-10-31 | FORM 10-Q | 0001640334-26-000174 | View SEC Doc Filr Page |
| 10-Q | 2026-01-23 | 2023-07-31 | FORM 10-Q | 0001640334-26-000128 | View SEC Doc Filr Page |
| 10-Q | 2026-01-13 | 2023-04-30 | FORM 10-Q | 0001640334-26-000076 | View SEC Doc Filr Page |
| 10-K | 2025-12-01 | 2023-01-31 | FORM 10-K | 0001640334-25-002237 | View SEC Doc Filr Page |
| 8-K | 2025-08-25 | 2025-08-19 | FORM 8-K | 0001683168-25-006448 | View SEC Doc Filr Page |
| 8-K | 2025-08-11 | 2025-08-05 | CURRENT REPORT | 0001683168-25-005896 | View SEC Doc Filr Page |
| 8-K | 2025-07-29 | 2022-08-26 | CURRENT REPORT | 0001683168-25-005467 | View SEC Doc Filr Page |
| NT 10-K | 2023-05-01 | 2023-01-31 | NT 10-K Filing | 0001697884-23-000004 | View SEC Doc Filr Page |
| 8-K | 2023-01-27 | 2023-01-17 | 8-K Filing | 0001697884-23-000002 | View SEC Doc Filr Page |
| 10-Q | 2022-12-21 | 2022-10-31 | 10-Q Filing | 0001697884-22-000018 | View SEC Doc Filr Page |
| NT 10-Q | 2022-12-13 | 2022-10-31 | NT 10-Q Filing | 0001697884-22-000015 | View SEC Doc Filr Page |
| 10-Q | 2022-09-15 | 2022-07-31 | 10-Q Filing | 0001697884-22-000013 | View SEC Doc Filr Page |